Afnet Redakteur

Anticoagulation in patients with device-detected atrial fibrillation remains individual decision

by

A Win Ratio analysis confirmed the primary result of the NOAH – AFNET 6 trial and did not find an advantage of anticoagulation with edoxaban over no anticoagulation in patients with device-detected atrial fibrillation. Clinical decisions should therefore be guided by individual factors. The findings were presented by Dr. Nina Becher, University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany, in a hotline session at the annual congress of the European Society of Cardiology (ESC) in Madrid. (1,2)

MAESTRIA Consortium Meeting took place on 8 & 9 of May at the Sorbonne University

by

Beiträge Aktuelles MAESTRIA Consortium Meeting took place on 8 & 9 of May at the Sorbonne University The leaders of the different work packages (WP1-WP8) presented their results from the respective sub-projects and defined further milestones. In addition to the work on AI analyses, Prof. Andreas Götte (WP4 leader) presented the successful implementation of the … Read more

Enrolment status update

by

Beiträge Aktuelles Enrolment status update Many thanks to the actively recruiting sites that enrolled patients in April and May: DE005 – Dr Meyer, EVK Düsseldorf, Germany = ES001 – Dr Filgueiras, Hospital Clinico San Carlos Madrid, Spain = DE022 – Prof Pott, Bonifatius Hospital Lingen, Germany = DE023 – Dr Rillig, Hamburg-Eppendorf, Hamburg, Germany = … Read more

Enrolment of permanent AF patients: screening tip

by

Beiträge Aktuelles Enrolment of permanent AF patients: screening tip The site in Brandenburg contacts its hospital’s internal controlling department, which has access to all hospital records. The controlling department compiles a monthly list of patients with the ICD code I48.2 which defines patients with permanent atrial fibrillation. All potential patients of this list are then … Read more